A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
about
Human epidermal growth factor receptor family-targeted therapies in the treatment of HER2-overexpressing breast cancerReceptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancersThe design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agentsA network module-based method for identifying cancer prognostic signaturesGrape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer.Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidenceHER2 assessment by silver in situ hybridization: where are we now?Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition.Metastatic and triple-negative breast cancer: challenges and treatment options
P2860
Q27025863-922CBBD9-BA8F-4EF9-9084-0CF8962270D8Q28082793-69EAA58A-53AA-4A49-8241-FC3D6D04D52AQ33872751-B97A5069-B214-4EB9-9E1F-4E85EF5980AFQ34646243-40B3ADB1-AD0E-43DA-84AA-28B719241FA8Q34855692-01357315-ACFB-45E7-BD74-30920C860CB1Q35677713-88D00E10-9CF4-4006-AA7F-B31B7964E15EQ36250585-1262BB18-CDFC-4C7B-976F-A6DEABFC7CBFQ38314355-85880D44-B801-4EDF-8F43-70B453498680Q38696082-18A053B0-B250-4BE7-9BC6-37F3CB21364EQ57105258-79D24A7D-1243-4428-84BD-C2A69AA23C6A
P2860
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A phase I/II prospective, sing ...... itive metastatic breast cancer
@en
A phase I/II prospective, sing ...... tive metastatic breast cancer.
@nl
type
label
A phase I/II prospective, sing ...... itive metastatic breast cancer
@en
A phase I/II prospective, sing ...... tive metastatic breast cancer.
@nl
prefLabel
A phase I/II prospective, sing ...... itive metastatic breast cancer
@en
A phase I/II prospective, sing ...... tive metastatic breast cancer.
@nl
P2093
P2860
P1476
A phase I/II prospective, sing ...... itive metastatic breast cancer
@en
P2093
C A Russell
C L Martel
M Koczywas
M McNamara
P2860
P2888
P304
P356
10.1007/S10549-011-1850-2
P407
P577
2011-11-01T00:00:00Z